600222 Henan Taloph Pharmaceutical Stock
- 4.79
- +0.06+1.27%
Henan Taloph Pharmaceutical Stock News
Tailong Pharmaceutical 2023 Annual General Meeting of Shareholders Meeting Materials
Announcement of Tarong Pharmaceutical's progress in providing guarantees to wholly-owned subsidiaries
Announcement of Tailong Pharmaceutical on holding the 2023 Annual Results Briefing
Talong Pharmaceutical's progress announcement on the repurchase of the company's shares through centralized bidding transactions
Asset evaluation report for the goodwill impairment test project formed by Henan Tailong Pharmaceutical Co., Ltd.'s acquisition of Beijing New Leading Pharmaceutical Technology Development Co., Ltd.
Tailong Pharmaceutical 2023 Internal Control Evaluation Report
Articles of Association of Tailong Pharmaceutical Co., Ltd. (Revised in March 2024)
Announcement of Tailong Pharmaceutical on the purchase of liability insurance for directors, supervisors, and senior executives
Announcement of Tailong Pharmaceutical requesting the shareholders' meeting to authorize the board of directors to issue shares to specific targets through simple procedures
Tailong Pharmaceutical 2023 Annual Report
Tailong Pharmaceutical 2023 Financial Statement Audit Report
Board of Directors Rules of Procedure
Independent director work system
Management Measures for Selecting and Hiring Accounting Firms
Rules of work for special meetings of independent directors
Board Audit Committee Implementation Rules
Board Strategy and Development Committee Implementation Rules
Board Nomination Committee Implementation Rules
Special audit report on the summary table of non-operating capital occupation and other related capital transactions of Tailong Pharmaceutical
Report of the Audit Committee of the Board of Directors of Tailong Pharmaceutical on the performance of supervisory duties by accounting firms in 2023
Analysis
Price Target
No Data
